Vectura is a breath of fresh air
Shareholders in Vectura* (VEC), of which I am one, should breathe easy following this morning’s results from the inhaled medicines specialist. Vectura has reported a maiden profit after tax of £3.7 million on the back of revenues up by 59% to £58 million. However, this is just the beginning, as Vectura is now a company…